Intervention

CNM-Au8

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions5

Lead sponsors shown1

Clinical trials

3 shown

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple SclerosisNCT04626921 · 2020-10-22

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple SclerosisNCT03536559 · 2018-11-23

Intermediate Expanded Access Protocol CNMAu8.EAP03NCT04081714

TEMPORARILY_NOT_AVAILABLE

Common conditions

Multiple Sclerosis1 Optic Neuropathy1 Optic; Neuritis, With Demyelination1 Relapsing Multiple Sclerosis1 Relapsing Remitting Multiple Sclerosis1

Leading sponsors

Clene Nanomedicine3

Trial status mix

COMPLETED1

TEMPORARILY_NOT_AVAILABLE1

TERMINATED1

Phase mix

PHASE22

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.